News
News releases on June 12, 2023, page 4
Every news release public companies put out on June 12, 2023 (UTC): 331 news releases, newest first. Open any release to read it.
Calumet Specialty Products Partners, L.P. Announces Cash Tender Offers for Any and All of its 9.25% Senior Secured First Lien Notes due 2...
Calumet, Inc · Jun 12, 2023
CalciMedica Announces Relisting on Nasdaq
CalciMedica, Inc. · Jun 12, 2023
BWR Exploration Provides Update on Permitting for Exploration on Little Stull Lake Gold Project Northeastern Manitoba
BWR Exploration Inc. · Jun 12, 2023
BullFrog AI revolutionizing precision medicine through artificial intelligence on bfLEAP platform
Bullfrog AI Holdings, Inc. · Jun 12, 2023
Brera Holdings PLC Names Pierre Galoppi CEO
Brera Holdings PLC · Jun 12, 2023
Blink Charging Announces Final Design and Development of New EV DC Fast Charger with Dual-Port CCS and NACS Connectors at EVS36
Blink Charging Co. · Jun 12, 2023
Bit Digital, Inc. Announces First Quarter of Fiscal Year 2023 Financial Results
Bit Digital, Inc. · Jun 12, 2023
BioRestorative Therapies Announces Key Milestone of Dosing Completion in Safety Cohort of Phase 2 Trial Targeting Chronic Lumbar Disc Dis...
BioRestorative Therapies, Inc. · Jun 12, 2023
Bionano Announces 2023 Winners of its Innovator Research Grant Program
Bionano Genomics, Inc. · Jun 12, 2023
Biogen Announces Changes to Its Board of Directors
Biogen Inc. · Jun 12, 2023
Biofrontera Inc. Sponsors The Sun Bus, Delivering Free Mobile Skin Cancer Screenings Across the U.S.
Biofrontera Inc. · Jun 12, 2023
Big Gold Mobilizes Field Team to Execute on 2023 Initial Exploration Program at Tabor Project, Ontario
Big Gold, Inc. · Jun 12, 2023
Austin Gold Drops Certain Claims at Kelly Creek
Austin Gold Corp. · Jun 12, 2023
Auddia Announces Launch of Its faidr 3.0 Mobile App
Auddia Inc. · Jun 12, 2023
Atossa Completes Enrollment of Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuva...
Atossa Therapeutics, Inc. · Jun 12, 2023
Art the Clown Is Back! Cineverse Secures North American Rights to TERRIFIER 3, the Highly Anticipated Slasher Film Sequel by Damien Leone...
Cineverse Corp. · Jun 12, 2023
Arqit and DETASAD Announce Strategic Teaming Agreement
Arqit Quantum Inc. · Jun 12, 2023
Arqit and DETASAD announce Strategic Teaming Agreement
Arqit Quantum Inc. · Jun 12, 2023
Aquana Announces New Remote Shutoff Valve for Water Utilities
Geospace Technologies Corporation · Jun 12, 2023
Applied Digital Announces Successful Integrated Systems Test at Jamestown, North Dakota Facility for HPC Deployment
Applied Digital Corporation · Jun 12, 2023
Appian Drives Productivity Revolution with Generative AI Strategy and Expanded AI Roadmap
Appian Corporation · Jun 12, 2023
Anavex Life Sciences Reports Publication in Medical Journal Signifying Continued Commitment for Improvement of the Rett Syndrome Caregive...
Anavex Life Sciences Corp. · Jun 12, 2023
American Lithium Completes Strategic Investment in Surge Battery Metals
American Lithium Corp. · Jun 12, 2023
Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®
Alvotech · Jun 12, 2023
AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for June 2023
AGNC Investment Corp. · Jun 12, 2023
ADS-TEC Energy ChargeBox selected by GSA for Green Proving Ground program to drive toward net-zero emissions in federal buildings
Ads-tec Energy PLC · Jun 12, 2023
ABVC BioPharma ADHD Phase II Part 2 Clinical Study First Subject Enrolled at UCSF
ABVC BioPharma, Inc. · Jun 12, 2023
2023 Scripps National Spelling Bee seen by 9.2 million viewers, up 22% vs. 2022
E.W. Scripps Company · Jun 12, 2023
18,000 Meters of Drilling Underway at Goliath’s Extensive New High-Grade Gold-Silver Discovery in the Golden Triangle, B.C.
Goliath Resources Limited · Jun 12, 2023
Som Distilleries & Breweries Ltd. Press Release Jun 12 2023
Som Distilleries & Breweries Ltd. · Jun 12, 2023
Zensar Technologies Limited Press Release Jun 12 2023
Zensar Technologies Limited · Jun 12, 2023